SUZHOU, China, March 29, 2024 /PRNewswire/ Alphamab Oncology (stock code: 9966.HK) reported financial results for the full year ended December 31, 2023 and
/PRNewswire/ Brii Biosciences Limited ("Brii Bio," "we," or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve.